A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine
Loading...
Files
Date
2019
Journal Title
Journal ISSN
Volume Title
Publisher
Korean Coll Neuropsychopharmacology
Access Rights
info:eu-repo/semantics/openAccess
Abstract
Rabbit Syndrome is an uncommon side effect of antipsychotic treatment. Although it is usually associated with typical antipsychotics, it can also be related to atypical antipsychotics. Anticholinergics are the most accepted treatment approach in treating Rabbit Syndrome. Fluvoxamine is a member of selective serotonin reuptake inhibitors and it is a potent agonist of sigma 1 receptors. In this article, we report a Rabbit Syndrome case who has benefited from fluvoxamine, in terms of both depressive disorder and Rabbit Syndrome; and present the data on the effects of sigma 1 agonist fluvoxamine on numerous movement disorders.
Description
Keywords
Rabbit syndrome, Sigma receptors, Side effect, Fluvoxamine, Serotonin Reuptake Inhibitors, Clinical-Implications, Tardive-Dyskinesia, Receptor Agonists, Chaperone, Ligands, Cortex, Brain, Scale
Journal or Series
Clinical Psychopharmacology and Neuroscience
WoS Q Value
Q3
Scopus Q Value
Q2
Volume
17
Issue
1
